Pediatric RSV Cases Rise – but Only in North America?

And who is mRNA-jabbing infants and young children? USA and Canada exclusively.
We can see that only USA and Canada (the absolute world “leader”) are intensively mRNA-jabbing young children (5-11) and babies 6 months to 4 years old from this chart of new vaccine recipients, i.e. the ones that didn’t qualify for jabs until very recently:

Another confirmation of the pediatric RSV spike being caused by the Covid-19 jabs has been available from Moderna and Pfizer’s clinical trials:
8:51 PM ∙ Nov 7, 2022
And this tweet says the cases are not unusual, but the number of kids ending in ICU is:

10:02 PM ∙ Nov 15, 2022
But if you try to find any news from Europe (check out the REspiratory Syncytial virus Consortium in EUrope‘s web site – not even on the radar!), or anywhere else in the world, you won’t find anything about the rise of acute cases of respiratory syncytial virus (RSV) among children and any hospital crunches (please let me know what YOU find). While on this side of the Atlantic, there is an avalanche of such news:
- “Pediatric hospital beds filled at highest rate in 2 years, data shows” (ABC News, 2022.11.07)
- “Hospitals scramble to find beds as pediatric admissions rise” (Boston Globe, 2022.10.21)
- ““It’s going to be a rough winter”: Hospitals overwhelmed by pediatric patients with respiratory virus” (CBS Evening News, 2022.10.20)
- “Children’s hospitals are overwhelmed across Canada. Experts weigh in on what’s to blame – and what’s not” (Globe and Mail, 2022.11.14)What to blame, asks Globe and Mail, and offers this expert opinion: “Experts say they’re also concerned over the fact too few children are vaccinated against the flu and COVID-19. In Alberta, only 7.5 per cent of one- to four-year-olds have gotten a flu shot. At the national level, only 1 per cent of children under 5 have received two doses of a COVID-19 vaccine.”
Long way to the bottom still, eh? And look at the timing of these articles coinciding perfectly with child “vaccinations”, commenced after FDA approving them based on the study of 8 blind mice. And these are the safety and efficacy characteristics of the jabs, in Moderna and Pfizer’s own words:
Side effects Between 21% to 26% of kids age 6 months to 5 years developed a fever after each dose of the Moderna vaccine, more than in adolescents and adults. Fever was less common in the Pfizer trial, reported in only 7% of children ages 6 to 23 months after each shot. In the Moderna trial, 62% of kids 3 to 5 years old experienced fatigue, compared with just under 45% of children age 2 to 4 years old in Pfizer’s trial.
Effectiveness Two doses of the Moderna vaccine are 51% effective in preventing infection in children 6 months to 2 years old, the company reported, and 37% in kids 2 through 5. The vaccine’s ability to prevent serious illness or hospitalization is expected to be higher.
Pfizer has reported its three-dose vaccine was 80% in preventing infection, but its research was based on a very small pool of subjects. More data will become available as its vaccine is rolled out widely.
If that is the most optimistic efficacy of these jabs, coming with this optimistic level of the most immediate adverse reactions, it’s nothing short of criminal to push them on the little ones.
Now we know for a fact who is behind this global madness of depopulation through mRNA “vaccination”, as conspiracy theorists have been warning us for decades. Don’t we?